A detailed history of Verition Fund Management LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 58,518 shares of AUPH stock, worth $468,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,518
Previous 18,935 209.05%
Holding current value
$468,729
Previous $108,000 296.3%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.32 - $7.33 $210,581 - $290,143
39,583 Added 209.05%
58,518 $428,000
Q2 2024

Aug 14, 2024

BUY
$4.81 - $5.78 $91,077 - $109,444
18,935 New
18,935 $108,000
Q2 2023

Aug 14, 2023

BUY
$8.96 - $11.69 $249,177 - $325,098
27,810 Added 73.79%
65,500 $634,000
Q1 2023

May 15, 2023

BUY
$5.94 - $11.27 $148,500 - $281,750
25,000 Added 197.01%
37,690 $413,000
Q4 2022

Feb 14, 2023

SELL
$4.11 - $8.14 $7,919 - $15,685
-1,927 Reduced 13.18%
12,690 $54,000
Q3 2022

Nov 14, 2022

SELL
$6.66 - $12.39 $146,526 - $272,592
-22,001 Reduced 60.08%
14,617 $110,000
Q2 2022

Aug 15, 2022

SELL
$8.95 - $12.8 $1.28 Million - $1.84 Million
-143,516 Reduced 79.67%
36,618 $368,000
Q4 2021

May 03, 2022

SELL
$17.78 - $33.08 $177,800 - $330,800
-10,000 Reduced 5.26%
180,134 $4.12 Million
Q4 2021

Feb 14, 2022

BUY
$17.78 - $33.08 $3.38 Million - $6.29 Million
190,134 New
190,134 $4.35 Million
Q4 2020

Feb 16, 2021

SELL
$12.94 - $16.05 $402,434 - $499,155
-31,100 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$13.19 - $16.66 $824,480 - $1.04 Million
-62,508 Reduced 66.78%
31,100 $458,000
Q2 2020

Aug 14, 2020

BUY
$14.12 - $18.33 $473,796 - $615,063
33,555 Added 55.88%
93,608 $1.52 Million
Q1 2020

May 15, 2020

BUY
$11.34 - $21.46 $158,748 - $300,418
13,999 Added 30.4%
60,053 $871,000
Q4 2019

Feb 14, 2020

BUY
$3.88 - $21.42 $178,689 - $986,476
46,054 New
46,054 $933,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.